Exploring community factors affecting opioid use disorder and treatment adherence
Official title: Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy
Funded at Geisinger Clinic · NIH-10864937 · Data updated 2026-11-12
This study is looking at how different community and program factors affect the risk of opioid use disorder and how well medication-assisted treatment works, with the goal of finding ways to help people stick with their treatment and improve their recovery.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Geisinger Clinic NIH-funded |
| Lab location | 1 site (Danville, United States) |
| Project start | July 1, 2020 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $162,032 |
| NIH project number | 5K01DA049903-05 |
| Project ID | NIH-10864937 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals aged 21 and older who are receiving or are eligible for medication-assisted treatment for opioid use disorder.
✕Less likely to help
Patients who are not currently engaged in treatment for opioid use disorder or those under 21 years old may not benefit from this research.
What this research studies
This research investigates how various community and program factors influence the risk of opioid use disorder (OUD) and the effectiveness of medication-assisted treatment (MAT). It aims to identify barriers to long-term treatment adherence and develop strategies to enhance patient retention in MAT programs. The project will utilize electronic health record data to conduct a two-phase epidemiologic study, providing insights that could improve treatment outcomes for individuals struggling with OUD. The research is supported by a team of experienced mentors and aims to equip the principal investigator with the skills needed for independent research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment adherence for patients with opioid use disorder, ultimately enhancing their recovery outcomes.
How similar studies have gone: Previous research has shown success in using community and programmatic factors to improve treatment adherence in similar populations, indicating that this approach has potential.
Where this research is happening
-
Geisinger Clinic
Danville, United States Active
Researchers
- Principal investigator: Poulsen, Melissa — Geisinger Clinic
- Study coordinator: Poulsen, Melissa
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.